About the The Neuroendocrine Tumor Research Foundation
The Neuroendocrine Tumor Research Foundation (NETRF) has announced a new round of research grant opportunities. Its 2019 Request for Applications (RFA) invites innovative research applications in neuroendocrine tumors (NETs) to increase our basic understanding of these uncommon tumors and lead to the development of more effective therapies. The grants range from $100,000 to $1.2 million to support projects ranging from one year to four years for basic, translational, or clinical research.
Our new two-year Mentored Award for Early Career Researchers
This year, NETRF will offer a new Mentored Award, a two-year grant for early career researchers, who are completing post-doctoral, residency, or fellowship positions. This grant is designed to recruit young talented scientists to the NET field at a pivotal point in their careers. The Mentored Award is supported through a grant from IPSEN.
“If you are just finishing up graduate school or your post-doctoral fellowship, you don’t have a lab unless you get funding, you don’t have a career unless you get funding to do research,” said George Fisher, MD, PhD, co-chair, NETRF Board of Scientific Advisors. “The Mentored Award will enable junior investigators to get a foothold by starting and finishing a project in order to build a career in neuroendocrine tumor research.”
NETRF welcomes proposals addressing gastrointestinal and pancreatic NETs and continues to have a special interest in lung NETs. Grants are open to researchers anywhere in the world.
“Our understanding of the cause and growth of neuroendocrine tumors lags behind other types of cancers,” said Elyse Gellerman, NETRF chief executive officer. “NETRF is looking for transformative projects that accelerate discovery and have the potential to improve treatments.”
Interested applicants must submit a letter of intent online by June 17, 2019. From that pool, investigators with the most promising and transformative ideas will be invited to submit full proposals. Proposals are selected using a rigorous peer review process, which includes external expert reviewers and NETRF’s Board of Scientific Advisors. Grant awardees will be notified in late 2019.
In 2018, NETRF funded 15 research studies with a combined value of $4.4 million. Awards were granted to investigators in the United States, Canada, Netherlands, Australia, and Switzerland. NETRF is the largest private funder of NET research. Since 2005, NETRF has funded $22 million in scientific research to expand the molecular understanding of NETs and help drive personalized treatment options for patients.
For more information on the NETRF RFA or to apply, go to netrf.org/for-researchers.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.